These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics. Qin H; Zhao A Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302 [TBL] [Abstract][Full Text] [Related]
6. Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury. Cattel F; Giordano S; Bertiond C; Lupia T; Corcione S; Scaldaferri M; Angelone L; De Rosa FG Respir Physiol Neurobiol; 2021 Jun; 288():103645. PubMed ID: 33657448 [TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches. Bosma KJ; Taneja R; Lewis JF Drugs; 2010 Jul; 70(10):1255-82. PubMed ID: 20568833 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic Treatments in Acute Respiratory Failure. Levy E; Reilly JP Crit Care Clin; 2024 Apr; 40(2):275-289. PubMed ID: 38432696 [TBL] [Abstract][Full Text] [Related]
10. Emerging drugs for treating the acute respiratory distress syndrome. Shaw TD; McAuley DF; O'Kane CM Expert Opin Emerg Drugs; 2019 Mar; 24(1):29-41. PubMed ID: 30841764 [TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome. Khiali S; Khani E; Entezari-Maleki T J Clin Pharmacol; 2020 Sep; 60(9):1131-1146. PubMed ID: 32557541 [TBL] [Abstract][Full Text] [Related]
12. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial. Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473 [TBL] [Abstract][Full Text] [Related]
13. The Role of MicroRNAs in Acute Respiratory Distress Syndrome and Sepsis, From Targets to Therapies: A Narrative Review. Lee LK; Medzikovic L; Eghbali M; Eltzschig HK; Yuan X Anesth Analg; 2020 Nov; 131(5):1471-1484. PubMed ID: 33079870 [TBL] [Abstract][Full Text] [Related]
14. Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses-a systematic review. Ragel EJ; Harris LK; Campbell RA BMJ Open Respir Res; 2023 Sep; 10(1):. PubMed ID: 37657844 [TBL] [Abstract][Full Text] [Related]
15. Understanding the pathophysiology of typical acute respiratory distress syndrome and severe COVID-19. Ball L; Silva PL; Giacobbe DR; Bassetti M; Zubieta-Calleja GR; Rocco PRM; Pelosi P Expert Rev Respir Med; 2022 Apr; 16(4):437-446. PubMed ID: 35341424 [TBL] [Abstract][Full Text] [Related]